106 related articles for article (PubMed ID: 22045829)
1. Pharmacokinetic-pharmacodynamic assessment of the interrelationships between tesaglitazar exposure and renal function in patients with type 2 diabetes mellitus.
Hamrén B; Ohman KP; Svensson MK; Karlsson MO
J Clin Pharmacol; 2012 Sep; 52(9):1317-27. PubMed ID: 22045829
[TBL] [Abstract][Full Text] [Related]
2. The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
Tonstad S; Retterstøl K; Ose L; Ohman KP; Lindberg MB; Svensson M
Metabolism; 2007 Sep; 56(9):1285-92. PubMed ID: 17697874
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function--evidence of interconversion.
Hamrén B; Ericsson H; Samuelsson O; Karlsson MO
Br J Clin Pharmacol; 2008 Jun; 65(6):855-63. PubMed ID: 18294322
[TBL] [Abstract][Full Text] [Related]
4. Food does not affect the pharmacokinetics of tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist.
Samuelsson S; Johansson S; Halldórsdóttir S; Stenhoff H; Ohman KP
J Clin Pharmacol; 2006 Sep; 46(9):1017-22. PubMed ID: 16920896
[TBL] [Abstract][Full Text] [Related]
5. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients?
Fontseré N; Salinas I; Bonal J; Bayés B; Riba J; Torres F; Rios J; Sanmartí A; Romero R
Nephrol Dial Transplant; 2006 Aug; 21(8):2152-8. PubMed ID: 16702203
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat.
Ovcharenko E; Hansen MK; Goltsman I; Abu-Saleh N; Abassi Z; Walsh K; Miele G; Feuerstein GZ; Winaver J
Nephron Physiol; 2010; 115(3):p21-30. PubMed ID: 20460939
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of atorvastatin on glomerular filtration rate, tubular function, blood pressure, and vasoactive hormones in patients with type 2 diabetes.
Paulsen L; Matthesen SK; Bech JN; Starklint J; Pedersen EB
J Clin Pharmacol; 2010 Jul; 50(7):816-22. PubMed ID: 20056802
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
Agarwal R
Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
[TBL] [Abstract][Full Text] [Related]
9. A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes.
Ribbing J; Hamrén B; Svensson MK; Karlsson MO
J Clin Pharmacol; 2010 Aug; 50(8):861-72. PubMed ID: 20484615
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus.
Bays H; McElhattan J; Bryzinski BS;
Diab Vasc Dis Res; 2007 Sep; 4(3):181-93. PubMed ID: 17907108
[TBL] [Abstract][Full Text] [Related]
11. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A
Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138
[TBL] [Abstract][Full Text] [Related]
12. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
Raml A; Schmekal B; Grafinger P; Biesenbach G
Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
[TBL] [Abstract][Full Text] [Related]
13. Effect of diabetes mellitus on glomerular filtration rate in an urban hospital diabetic population.
Odutola TA; Mabadeje AF; Mabayoje MO
Afr J Med Med Sci; 1997; 26(1-2):19-21. PubMed ID: 10895222
[TBL] [Abstract][Full Text] [Related]
14. The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes.
Göke B; Gause-Nilsson I; Persson A;
Diab Vasc Dis Res; 2007 Sep; 4(3):204-13. PubMed ID: 17907110
[TBL] [Abstract][Full Text] [Related]
15. Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function.
Yossepowitch O; Eggener SE; Serio A; Huang WC; Snyder ME; Vickers AJ; Russo P
J Urol; 2006 Oct; 176(4 Pt 1):1339-43; discussion 1343. PubMed ID: 16952626
[TBL] [Abstract][Full Text] [Related]
16. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
19. Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats.
Liao J; Soltani Z; Ebenezer P; Isidro-Carrión AA; Zhang R; Asghar A; Aguilar E; Francis J; Hu X; Ferder L; Reisin E
Nephron Exp Nephrol; 2010; 114(2):e61-8. PubMed ID: 19887847
[TBL] [Abstract][Full Text] [Related]
20. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
